Preliminary Clinical Data From Ongoing Phase 2 Study With Enhancer of Zeste Homolog 2 (EZH2) Inhibitor CPI-0209 in Patients With Advanced Solid Tumors or Hematologic Malignancies

  1. Kindler, H.
  2. Harvey, R.D.
  3. Duska, L.R.
  4. Gandhi, L.
  5. Sullivan, R.J.
  6. Gastinne, T.
  7. Kwiatek, M.
  8. García-Sancho, A.M.
  9. Hadar, N.
  10. Kann, L.
  11. Faulhaber, N.
  12. Drescher, C.
Revue:
European Journal of Cancer

ISSN: 1879-0852,  0959-8049

Année de publication: 2022

Volumen: 174

Pages: S31-S32

Type: Article

DOI: 10.1016/S0959-8049(22)00884-X GOOGLE SCHOLAR lock_openAccès ouvert editor

Objectifs de Développement Durable